To determine how methylation of K427 would affect JMJD2D’s function, we examined if the R427 mutation would tamper the interaction of JMJD2D with two of its prostate cancer-relevant interaction partners, the tumor suppressor p53 and the ETS protein ETV1 (11, 19). The gene discussed is TP53; the disease is prostate cancer.